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ABSTRACT
￿
1-Deoxynojirimycin is a specific inhibitor of glucosidases I and II, the first enzymes
that process N-linked oligosaccharides after their transfer to polypeptides in the rough
endoplasmic reticulum . In a pulse-chase experiment, 1-deoxynojirimycin greatly reduced the
rate of secretion of a1-antitrypsin and al -antichymotrypsin by human hepatoma HepG2 cells,
but had marginal effects on secretion of the glycoproteins C3 and transferrin, or of albumin .
As judged by equilibrium gradient centrifugation, 1-deoxynojirimycin caused al-antitrypsin
and al-antichymotrypsin to accumulate in the rough endoplasmic reticulum . The oligosac-
charides on cell-associated al-antitrypsin and al-antichymotrypsin synthesized in the pres-
ence of 1-deoxynojirimycin, remained sensitive to Endoglycosidase H and most likely had the
structure Glu 1- 3Man9GIcNAC2 . Tunicamycin, an antibiotic that inhibits addition of N-linked
oligosaccharide units to glycoproteins, had a similar differential effect on secretion of these
proteins . Swainsonine, an inhibitor of the Golgi enzyme a-mannosidase II, had no effect on
the rates of protein secretion, although the proteins were in this case secreted with an
abnormal N-linked, partially complex, oligosaccharide . We conclude that the movement of
al-antitrypsin and al-antichymotrypsin from the rough endoplasmic reticulum to the Golgi
requires that the N-linked oligosaccharides be processed to at least the Man9GlcNAc2 form ;
possibly this oligosaccharide forms part of the recognition site of a transport receptor for
certain secretory proteins .
Secretory proteins and cell surface glycoproteins are synthe-
sized on ribosomes attached to the rough endoplasmic retic-
ulum membrane . Cotranslationally, the polypeptides are
transported across or inserted into the rough endoplasmic
reticulum membrane (1-3), and one or more oligosaccharides,
of structure G1c 3Man9GlcNAc2 , are transferred to specific asn
residues (4) . By a series of membrane vesicles these proteins
are transported first to the Golgi complex of membranes, then
to the cell surface (1-3, 5, 6) .
How proteins move from the rough endoplasmic reticulum
to the Golgi is not known . A common hypothesis is that small
vesicles bud off from a specialized region of the rough endo-
plasmic reticulum, containing a sample of the luminal con-
tents and membrane proteins. These vesicles subsequently
fuse with vesicles of the cis- (or proximal) region ofthe Golgi
cisternae (2, 3) . In hepatic parenchymal cells albumin and
lipoprotein particles are localized to different terminal dila-
tions of the rough endoplasmic reticulum and cis-Golgi (7) .
Thus it is possible that different vesicles transport different
secretory products to the Golgi .
It is generally believed that all secretory and plasma mem-
brane glycoprotein proteins migrate through the same Golgi
vesicles . A combination of cell-fractionation and immunoe-
lectronmicroscopic approaches has shown that albumin,
transferrin, and the vesicular stomatitis viral glycoprotein and
other glycoproteins are found in the same rough endoplasmic
reticulum and Golgi cisternae (8-12) . All ofthe predominant
proteins secreted by the exocrine pancreas, likewise, are found
in the same series of intracellular vesicles (13). Additionally,
the high mannose oligosaccharides added to all of these pro-
teins undergo the same intracellular modifications (4) : Three
glucose residues and probably one or more mannose residues
THE JOURNAL OF CELL BIOLOGY " VOLUME 98 MAY 1984 1720-1729
0 The Rockefeller University Press - 0021-9525/84/05/1720/10 $1 .00are removed in the rough endoplasmic reticulum by three
enzymes, two glucosidases and an a-mannosidase, that are
localized to this organelle (14-16) . The remaining processing
enzymes are localized to cis- or trans-Golgi vesicles (4, 6, 14,
17, 18) .
Different secretory andmembrane proteins mature through
this intracellular pathway at very different rates (19-22) . In
HepG2 cells, at 32°C only 30 min are required for newly-
made albumin and a l-antitrypsin to mature to the Golgi .
About 50 min are required for C3 complement and a 1-
antichymotrypsin, and -150 min for transferrin. The rate-
limiting and distinctive step in intracellular maturation of
these proteins is in movement from the rough endoplasmic
reticulum to the Golgi, as secretion of all proteins from the
Golgi requires about the same period of time-20 min (20) .
We (19, 20) and others (21) have postulated that one or more
receptor proteins in the endoplasmic reticulum membrane
regulates the selective transport of secretory proteins or mem-
brane glycoproteins into transport vesicles en route to the
Golgi .
The function of the N-linked oligosaccharides in intracel-
lular maturation has been probed most often with tunicamy-
cin, an inhibitor ofsynthesis ofthe oligosaccharide precursor
(23). Many, but not all, glycoproteins fail to be secreted or to
be expressed on the cell surface if normal glycosylation is
inhibited (24-29) . Interpretation of these results is difficult,
however, since in specific cases unglycosylated proteins have
been shown to be more sensitive to proteases (28, 30), less
soluble (27, 31), or abnormally folded (32) .
In this paper, we have studied the effect of 1-deoxynojiri-
mycin and two other inhibitors of oligosaccharide processing
on intracellular maturation and secretion of five proteins by
human hepatoma HepG2 cells. 1-deoxynojirimycin inhibits
glucosidases I and II, the first enzymes that process N-linked
oligosaccharides after their attachment to proteins (33) . We
show that efficient maturation of some, but not all, secreted
glycoproteins from the rough endoplasmic reticulum to the
Golgi requires that the glucose residues on N-linked oligosac-
charides be removed . One interpretation ofour results is that
a Man9GlcNAc 2 oligosaccharide might be required for certain
secretory proteins to bind to a putative transport receptor .
After this manuscript was submitted, a paper by Gross et
al . (34) appeared that showed that 1-deoxynojirimycin inhibits
both oligosaccharide processing and secretion of a 1-protein-
ase inhibitor (al-antitrypsin), one of the proteins we have
studied, in primary hepatocytes.
MATERIALS AND METHODS
Materials :
￿
Swainsonine was a generous gift of Drs. D. Tulsiani and O .
Touster, Vanderbilt University, and 1-deoxynojirimycin was generously pro-
vided by Drs . E . Truscheit and D . Schmidt, Bayer A . G ., Elberfeld, Federal
Republic ofGermany . Rabbit antisera directed toward human albumin, trans-
ferrin, al-antitrypsin, al-antichymotrypsin, and C3 complement were pur-
chased from DAKO Immunoglobulins, a/s . Fixed Staphylococcus aureus cells
were purchased from the New England Enzyme Center, Inc . (Boston, MA),
and ["S]methionine from the Radiochemical Center, Amersham Corp ., Ar-
lington Heights, IL .
Growth and Labeling of HepG2 Cells :
￿
Culture dishes of 60-
mm diam were seeded with 1 .5 x 106 HepG2 cells, and incubated at 37°C in
Eagle's minimal essential medium supplemented with 10% fetal calf serum
(35). Cultures were generally fed on the second day after seeding and used on
the fourth, at which time the cells had approximately doubled. Similar to our
previous study (20) the cells were washed twice in complete PBS, placed in 1 .0
ml methionine-free growth medium (MEM medium, Flow Laboratories, Inc .,
containing 10% dialyzed fetal calf serum), and incubatedat 30 .5 or 32°C. After
20 min, 40 raCi ["S]methionine was added, and the culture incubated for a
further 10 min (pulse) . The plates were washed twice with PBS, and 2 ml chase
medium (growth medium plus 10% fetal calf serum and 1 mM methionine)
was added to each . After incubation at 32°C for the appropriate time (chase)
the cultures were placed at room temperature . The medium was saved, and
clarified by centrifugation at 10,000 g for 10 min at 4°C . Control studies
indicated that the total amount ofacid precipitable ["Slradioactivity (cells plus
medium) did not change more than 10% after chase periods up to 300 min.
Additionally, immunoprecipitation studies (below) showed that there was
<I0% increase in radioactivity in any of the five proteins studied during the
chase period, indicating that the chase was effective .
In the kinetic study (Figs. 1 and 2) medium wasremoved at 30 min ofchase,
and replaced with fresh prewarmed medium, and incubation was continued at
32°C . The process was repeated every 30 or 60 min until 240 min . The cells
were washed thrice in complete PBS, and lysed by addition of 1 .4 ml lysis
buffer (0.14 M NaCl, 0.004M KCI, 0.001 M NaF'0 4; 0.02M Tris, pH 7 .4; 1%
sodium deoxycholate ; 1% NP40). The lysate was clarifiedby centrifugation for
10 min at top speed in an Eppendorf microcentrifuge, and used forquantitative
immunoprecipitation .
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FIGURE 1
￿
Effects of tunicamycin, 1-deoxynojirimycin, and swain-
sonine on secretion of hepatoma proteins . Four 60-mm culture
dishes of HepG2 cells were placed in methionine-free medium
containing either 10 ug/ml tunicamycin, 10mM 1-deoxynojirimycin,
2 ug/ml swainsonine, or no drug (control) . As detailed in Materials
and Methods, the cells were labeled with [ 3sS]methionine and then
chased, all in the continuous presence of the drugs . At 30, 60, 90,
120, 180, and 240 min of chase the medium was removed from all
cultures, and replaced with fresh medium containing drugs, and
the cells were replaced in the 32°C incubator . At 240 min the cells
were lysed, as detailed in Materials and Methods . An equal aliquot
of the lysate and all media was subjected, in duplicate, to precipi-
tation with trichloracetic acid . From the amounts of radioactive
protein released into the medium during the six intervals sampled,
cumulative release of radioactive proteins into the medium can be
calculated (upper left) . Similarly, each of the media and the lysates
were subjected to quantitative immunoprecipitates with each of
the five antibodies noted, and the immunoprecipitation analyzed
by gel electrophoresis and fluorography . The gels were scanned
with a microdensitometer under conditions where the response of
the film and the instrument was in the linear range . The areas under
the relevant peaks(s) of the scan was a measure of the amount of
radioactive protein released into the medium during the interval
sampled, or remaining in the cells at 240 min . From these data (Fig.
2), one can calculate the cumulative amount of each protein re-
leased into the medium as function of the time of chase . O, control ;
O, swainsonine ; x, 1-deoxynojirimycin ;" , tunicamycin .
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￿
Effect of 1-deoxynojirimycin on secretion of albumin (a), al-antitrypsin and transferrin (b), and C3 complement (c) .
As detailed in the legend to Fig . 1, HepG2 cells were pulse-chased labeled in the presence (lanes 8-14) or absence (control,
lanes 1-7) of 1-deoxynojirimycin . Equal aliquots of medium and lysate were subjected to quantitative immunoprecipitation with
antialbumin (a), anti-al-antitrypsin, and antitransferrin together (b), and anti-C3 complement (c) . Lanes 1 and 8, protein secreted
between 0 and 30 min of chase; lanes 2 and 9, protein secreted between 30 and 60 min of chase; lanes 3 and 10, protein
secreted between 60 and 90 min of chase ; lanes 4 and 11, protein secreted between 90 and 120 min of chase; lanes S and 12,
protein secreted between 120 and 180 min of chase ; lanes 6 and 13, protein secreted between 180 and 240 min of chase; lanes
7 and 14, protein remaining in the cells after 240 min of chase . In b, arrows indicate (top down) the mature secreted form of
transferrin ; the intracellular form that is sensitive to Endo H ; the mature secreted form of al-antitrypsin; and the two intracellular
forms of al -antitrypsin that are generated in the presence of 1-deoxynojirimycin . In c, the arrows indicate proC3 ; and the two
cleaved products C3a and C3ß .
Immunoprecipitations :
￿
Reactions (20)contained 200,ullysisbuffer,
100 pl lysate or medium, and 10 rl of appropriate rabbit antiserum . After
incubation at 4°C for 1 h, with intermittentshaking, 50 Al ofa 10% suspension
offixed, washed, Staphylococcus aureus cells (29) was added . Immunoprecipi-
tates were recovered and washed as before (29) except that no SDS was used in
the buffers. These were dissolved in SIDS-containing buffer and analyzed by
electrophoresis through 10% polyacrylamide gels .
Controls established that these conditions were sufficient to recover >85%
of the labeled protein in question . In particular, <10% additional labeled
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protein was recovered ifthe first supernatant from the immunoprecipitation
was reacted with additional antiserum . In some cases, the immunoprecipitate
were split into two portions ; one was digested with Endoglycosidase H (Endo
H) and the other mock-digested, as detailed previously (36).
Subcellular Fractionation of HepG2 Cells Pulse-chase La-
beled with [35S]Methionine: This protocol is similar to the one we
used previously (20). For each sample, two 100-mm-diam culture dishes of
HepG2 cells were labeled for 15 min with 150 ,ACi ["Sjmethionine per plate,then chased for 55 min at 32*C with unlabeled methionine . All subsequent
procedures were done at 0°-4°C . The cells were washed twice in complete PBS,
scraped from the dish, and resuspended in 2 .5 ml buffer A (0.025 M HEPES,
0.05 M KCI, 0.002 M Mg acetate2 ., pH 7.2, 1 mM dithiothreitol) containing
10% (wt/vol) sucrose. After swelling for 10 min, the cells were disrupted with
80 strokes in a tight-fitting Dounce homogenizer. Nuclei were removed by
centrifugation at 1,000 g for 10 min . 2 .5 ml of cytoplasm was layered on 1 .0
ml 65% (wt/vol) sucrose and 2 .0 ml 15% sucrose, all in buffer A, in a tube for
the SW50 .1 Beckman ultracentrifuge rotor (Beckman Instruments, Inc .). Fol-
lowing centrifugation for 75 min and 40,000 rpm, the membranes were
recovered with a syringe at the 15-65% sucrose interphase . These were diluted
to 15% sucrose, with buffer A, containing no sucrose, and layered upon a
sucrose gradient (1 .1 ml each of 65, 55, 50, 45, 40, 35, 30, and 20% wt/vol, all
in buffer A) in a tube for the SW41 Beckman ultracentrifuge rotor. This was
centrifuged for 2 h and 40,000 rpm . Nineteen equal 0 .6 ml fractions were
collected.
RESULTS
To probe the role of asn-linked oligosaccharides in the secre-
tion of serum proteins by HepG2 cells, we have utilized three
inhibitors of oligosaccharide synthesis or processing . Tuni-
camycin blocks the first step in the biosynthesis of
G1c3Man9GIcNAc2 pyrophosphory1dolichol ; in its presence
no asn-linked oligosaccharide units are added to glycoproteins
(reviewed in reference 23) . 1-deoxynojirimycin is an inhibi-
tor of the oligosaccharide processing enzymes glucosidase
I and II . This compound blocks the formation of complex
oligosaccharides, and causes the accumulation of gluco-
sylated, high-mannose oligosaccharides of the structure
Glc l_3Man9GlcNAc 2-asn (33, 34) . Swainsonine is a specific
inhibitor ofthe processingenzyme a-mannosidase II (37) and
causes the accumulation of the processing intermediate
MansGlcNAc2-asn . A hybrid oligosaccharide of the following
structure:
Man
Man
a-l,3
Sialic -Gal-G1cNAc-Man
acid
Man
ß-1,4
G1cNAc
ß-I'4
Glc NAc-asn
Fucose
is found on secreted al-antitrypsin and on viral glycoproteins
synthesized in the presence of Swainsonine (38-40).
Swainsonine Does Not Affect the Rate of
Protein Secretion
Swainsonine has no effect on the rate or extent of secretion
of the five proteins studied : the glycoproteins al-antitrypsin,
al-antichymotrypsin, C3 complement, transferrin, and the
nonglycosylated protein albumin (Fig. 1 and Table 1) . The
glycoproteins secreted in the presence of this drug are, how-
ever, abnormal . On sodium dodecyl sulfate gels they migrate
faster than do the normal secreted forms (Figs . 3 and 4, lanes
7, compare with lanes 5), yet slower than do the pulse labeled
intracellular forms (compare lanes 7 and 3) . Whereas the
normal secreted forms of transferrin, al-antitrypsin, and al-
antichymotrypsin are resistant to EndoH (20 ; cf. Fig. 5, lanes
11 and 12) those secreted in the presence of swainsonine are
sensitive . Endo H generates a species that co-migrates with
the pulse-labeled cellular protein that has been treated with
Endo H (data not shown) . These results are compatible with
the conclusion that the oligosaccharides on proteins secreted
TABLE I
Effect of Inhibitors on Protein Secretion
The data in Fig. 1 were used to determine the time (minutes) required for
50% of each protein to be secreted .
* 10 tag/m1 .
' 5 mM .
' 2,ug/ml.
in the presence ofswainsonine have the hybrid structure noted
above; this hybrid structure is sensitive to Endo H (38-40) .
I-Deoxynoiirimycin Slows the Secretion of
Certain HepG2 Proteins
Figs. 1 and 2 and Table I show that 1-deoxynojirimycin
markedly slows the rate of secretion of newly-made al-anti-
trypsin . Whereas half of the newly-made protein is normally
secreted in <50 min, in the presence of 1-deoxynojirimycin
over 200 min are required for secretion of 50% of al-anti-
trypsin . This drug has a less dramatic effect on secretion of
C3 complement (half-time increased from 80 to 120 min) and
al-antichymotrypsin (75 to 165 min). There is no effect on
secretion of albumin or transferrin, results that indicate that
the drug is not a general "poison" ofcellular metabolism, and
that inhibition of secretion is highly selective . Similar results
(not shown) were obtained with concentrations of 1-deoxy-
nojirimycin from 5 to 25mM.
Inhibition of Processing by 1-Deoxynoiirimycin
Is Incomplete
Most of the small amount of al-antitrypsin and al-anti-
chymotrypsin secreted in the presence of 1-deoxynojirimycin
co-migrates with authentic secretory proteins (Fig. 2 b ; Fig. 3,
lanes 5 and 6; Fig . 4, lanes 5 and 6) and are resistant to Endo
H (Fig. 5, lanes 11-16). These proteins could contain the
normally processed "complex" oligosaccharides ; thus the in-
hibition of glucosidases I and II would not be total under the
conditions we used . Alternatively, the branch of the N-linked
oligosaccharides that contains the three glucose residues (that
attached to the a 1 -* 3 linked core mannose) could remain
unprocessed, while the other two branches, derived from the
a1 -. 6 linked core mannose, could be processed to the
complex form. The oligosaccharides would then have the
composition (sialic acid gal gIcNAc)2(Glc l-3Man 2)Man3
G1cNAc 2 . To resolve this point, we took advantage of the
finding that swainsonine blocks the conversion of the
branches attached to the a 1 -> 6 linked core mannose to the
complex form (37-40) . Thus we added swainsonine and 1-
deoxynojirimycin together to HepG2 cells. Figs. 3 and 4 (lanes
8) show that the proteins secreted co-migrate with the form
synthesized in the presence of swainsonine alone (compare
with lanes 7) . They are also sensitive to Endo H (not shown) .
If I-deoxynojirimycin were to cause the secretion ofthe hybrid
oligosaccharide noted above, then the combination of I-
deoxynojirimycin and swainsonine would block all of the
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Protein
Con-
trol
Tunica-
mycin*
1-deox-
ynojiri-
mycin*
Swain-
sonines
Albumin 47 42 44 47
al -antitrypsin 44 157 207 44
C3 82 114 121 79
at-antichymotrypsin 75 94 166 79
transferrin 170 154 180 153FIGURE 4
￿
Effect of swainsonine and 1-deoxynojirimycin on secre-
tion and gel mobility of al -antichymotrypsin . The protocol is iden-
tical to that of Fig . 3, except immunoprecipitates using anti-al-
antichymotrypsin were analyzed .
branches of the oligosaccharide from conversion to a complex
oligosaccharide. The expected secretory product would have
the composition Glc,-3Man 7GlcNAc2 ; proteins with this oli-
gosaccharide would migrate faster than the pulse labeled
intracellular form, not slower, as was found (Figs . 3 and 4) .
Most likely, therefore, 1-deoxynojirimycin inhibition of
glucosidases was incomplete and some protein with normal
complex oligosaccharides are produced. In the presence of
both 1-deoxynojirimycin and swainsonine, the hybrid struc-
ture that swainsonine generates is found on most of the
secreted glycoproteins.
I-Deoxynojirimycin Causes Accumulation of
Inhibited Secretory Proteins in the Rough
Endoplasmic Reticulum
The first set ofexperiments that established this pointmade
use of Endo H . Endo H cuts the G1cNAc ßl --- 4 G1cNAc
bond in asn-linked oligosaccharides, leaving only a single
G1cNAc residue attached to the protein . Substrates for Endo
H include the G1c3Man9GlcNAc 2 oligosaccharide transferred
in the rough endoplasmic reticulum to asn residues of glyco-
proteins, and processing intermediates such as Man9GlcNAc2,
Man8G1cNAc 2 , and Man5GlcNAc2 . Later intermediates in the
processing to complex oligosaccharides are resistant to Endo
H (41-43) . Fig. 5 (lanes 1 and 2) shows that in control cells,
pulse labeled al-antitrypsin, and transferrin are sensitive to
Endo H . The slower migrating mature form secreted into the
medium after a chase period is resistant to Endo H (lanes 11
and 12) as is the co-migrating form that accumulates tran-
siently in the cells during the chase period (lanes 3 and 4) .
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FIGURE 3
￿
Effect of swainsonine and 1-deoxyno-
jirimycin on secretion and gel motility of al-anti-
trypsin and transferrin . One set of cells (lanes 1-4)
was pulse-labeled for 10 min with ["Slmethionine,
lysed, and immunoprecipitated with a mixture of
antitransferrin and anti-al-antitrypsin . Another
(lanes 5-12) was pulse-labeled for 10 min and then
chased for 150 min ; the lysate (lanes 9-12) and
medium (lanes 5-8) were immunoprecipitated .
Lanes 1, 5, and 9, control ; lanes 2, 6, and 10, 10
mM 1-deoxynojirimycin ; lanes 3, 7, and 11, 2 wg/
ml swainsonine; lanes 4, 8, and 12, 10 mM 1-
deoxynojirimycin and 21'g/ml swainsonine . Shown
is an autoradiograph of the fixed, dried gel .
In the presence of 1-deoxynojirimycin, pulse-labeled trans-
ferrin migrates identically to its normal counterpart, and is
sensitive to Endo H (Fig. 5, lanes 5 and 6) . al-antitrypsin
synthesized in the presence of 1-deoxynojirimycin migrates
as two discrete polypeptides, the slowest migrating of which
migrates a bit slower than does its normal counterpart (com-
pare lanes 1 and 6) . Mammalian al-antitrypsin normally
contains three asn-linked oligosaccharides (44, 45). We sug-
gest that the slowest intracellular migrating species of a 1-
antitrypsin, synthesized in the presence of 1-deoxynojirimy-
cin, contains three oligosaccharides of the structure
Glc,_ 3Man9GlcNAc2 . The recent paper by Gross et al . (34)
establishes this structure directly . Such a protein would mi-
grate on SDS gels slower than would its normal counter-
part which contains three oligosaccharides of structure
Man9GlcNAc2 ; the three glucose residues are cleaved from
normal proteins very quickly (4) . The faster migrating species,
synthesized in the presence of 1-deoxynojirimycin, would
contain only two such oligosaccharides . As evidence for this
point, EndoH converts all forms ofpulse labeled a 1-antitryp-
sin to the same nonglycosylated species (Fig . 5, lanes 2 and
5) .
Half of the pulse labeled al-antitrypsin is normally con-
verted to an Endo H resistant form after a 30-min chase (Fig .
5, lanes 3 and 4; see reference 20) . In the presence of 1-
deoxynojirimycin, however, all forms of the cell-associated
al-antitrypsin remained Endo H sensitive, even after chase
periods of 60 min (lanes 7-10) or longer (not shown). Simi-
larly, in 1-deoxynojirimycin-treated cells, over 90% of the
pulse labeled al-antichymotrypsin, associated with the cells
after a chase period of up to 120 min, remained sensitive to
Endo H (data not shown). Since the enzymes that process
asn-linked oligosaccharides to an Endo H-resistant form are
localized to the Golgi, these results are consistent with the
notion that 1-deoxynojirimycin selectively blocks the matura-
tion of al-antitrypsin and al-antichymotrypsin from the
rough endoplasmic reticulum to the Golgi complex .
To confirm that 1-deoxynojirimycin selectively blocks the
maturation of secretory proteins at the level of the rough
endoplasmic reticulum, we employed subcellular fractiona-
tion experiments. Cells were either pulse labeled with ["S]
methionine, or pulse labeled and then chased for 55 min at
32°C . A postnuclear membrane fraction was prepared and
centrifuged to equilibrium through a sucrose density gradient .
Neither the rough endoplasmic reticulum or Golgi vesicles
have been purified to homogeneity from any tissue culture
cell . Thus, we must assume that a labeled secretory protein
which bands at 1 .10-1 .16 g/cc is in Golgi vesicles, and not insome other smooth-surfaced vesicles, and that secretory pro-
teins banding at 1 .18 g/cc are in rough endoplasmic reticulum
vesicles . Indeed, over 85-90% ofpulse labeled a 1-antitrypsin,
albumin, C3, a 1-antichymotrypsin, and transferrin bands in
membranes at a density of 1 .16-1 .20 g/cc, the density of
rough endoplasmic reticulum (data not shown) . Confirming
our previous result (20), all of the mature, sialic-acid bearing
al-antitrypsin and al-antichymotrypsin that accumulates in-
tracellularly during the chase period bands in the 1 .10-1 .16
g/cc region (Fig. 6, fractions 9-14). We recognize, of course,
that other smooth cellular membranes such as the smooth
endoplasmic reticulum and plasma membrane will bind in
this region ofthe gradient, butwe feel it unlikely that secretory
proteins would be associated with these organelles, and not
with the Golgi vesicles .
In control cells, after the 55-min chase period 75% of
labeled intracellular albumin bands at the density of smooth
surfaced membranes such as the Golgi (fractions 8-16, Fig .
6 ; cf . reference 20). About 77% of al-antitrypsin, and all of
the mature Endo H resistant a1-antitrypsin, likewise bands at
the density of the Golgi (Fig. 6) . 1-deoxynojirimycin has no
effect on the subcellular distribution of albumin . Importantly,
in the presence of 1-deoxynojirimycin 76% of labeled al-
antitrypsin bands at the density of the rough endoplasmic
reticulum . Clearly 1-deoxynojirimycin selectively blocks the
maturation of this protein from the rough endoplasmic retic-
ulum .
Quantitatively, in the control cells by 55 min of chase
-80% of pulse-labeled al-antitrypsin has been secreted, and,
of the 20% that remains in the cell, 77% bands in the Golgi
region . Thus, 95% (= 0.80 + (0.20)(0.77)) of al-antitrypsin
hasmoved to or through the Golgi within 55 min of synthesis .
In 1-deoxynojirimycin treated cells at 55 min of chase, by
contrast, only 6% of labeled al-antitrypsin has been secreted,
and ofthat remaining in the cell, 24% is in the Golgi fraction .
Thus, only 28% (= 0.06 + (0.94)(0.24)) of the protein has
moved to or through the Golgi vesicles within 55 min of its
synthesis .
In control cells, after the chase period, proteins such as al-
antichymotrypsin, which are secreted at an intermediate rate,
distribute on the density gradient in an intermediate fashion
(20) . In this study -60% are in the rough endoplasmic retic-
ulum, and all of the Endo H resistant a l-antichymotrypsin
bands with the Golgi (Fig. 6). By contrast, in the presence of
1-deoxynojirimycin over 75% of cell associated labeled al-
antichymotrypsin is associated with the rough endoplasmic
reticulum . Thus most if not all of the inhibitory effect of 1-
FIGURE 5
￿
Digestion of transferrin and al-antitryp-
sin, synthesized in the presence of 1-deoxynojiri-
mycin, with Endo H . Immunoprecipitates of al-an-
titrypsin and transferrin were split into equal aliquots ;
one was digested with Endo H (lanes 2, 3, 5, 7, 9, 11,
13, and 15) and the others undigested . Lanes 1 and
2, control cells, pulse labeled ; lanes 3 and 4, control
cells, chased 30 min ; lanes 5 and 6, 1-deoxynojiri-
mycin-treated cells, pulse-labeled ; lanes 7 and 8, 1-
deoxynojirimycin-treated cells, chased 30 min ; lanes
9 and 10, 1-deoxynojirimycin-treated cells, chased
60 min ; lanes 11 and 12, medium from control cells
chased 180 min; lanes 13 and 14, medium from 1-
deoxynojirimycin-treated cells, chased 90 min ; lanes
15 and 16, medium from 1-deoxynojirimycin-treated
cells, chased 180 min .
deoxynojirimycin on al-antichymotrypsin secretion is also
due to a block in maturation at the level of the rough
endoplasmic reticulum .
Transferrin requires the longest period of time to mature
from the rough endoplasmic reticulum to the Golgi (19, 20) .
After 55 min ofchase almostall ofthe pulse labeled transferrin
fractionates with the rough endoplasmic reticulum, and 1-
deoxynojirimycin has, as might be expected, no effect on this
profile .
Inhibition of Secretion by I-Deoxynoiirimycin Is
Reversible and Occurs Early in the
Secretory Pathway
In the experiment summarized in Table II, 1-deoxynojiri-
mycin was added to cells during the labeling period and the
first 30 (sample 3) or 60 min (sample 4) ofthe chase period,
then removed . During the next 180-210 min almost all of
the pulse labeled al-antitrypsin was secreted. In the continu-
ous presence of 1-deoxynojirimycin, by contrast, only 38% of
the protein was secreted by 240 min . Thus, the block in
secretion of al-antitrypsin, synthesized in the presence of 1-
deoxynojirimycin, can be reversed ifthe drug is subsequently
removed . The secreted protein co-migrates with authentic a 1-
antitrypsin (not shown) .
The experiment with sample 5, Table II, confirms that
inhibitionby 1-deoxynojirimycin occurs early in the matura-
tion pathway . If the drug is added at 20 min of the chase
period there is no effect on either the extent (line 5) or rate
(data not shown) of secretion oflabeled a 1-antitrypsin . By 20
min of chase only 60-70% of the labeled al-antitrypsin still
remains in the rough endoplasmic reticulum. It is expected
that the glucose residues will have been removed already from
that fraction of the al-antitrypsin still in the rough endo-
plasmic reticulum and thus that 1-deoxynojirimycin will have
no effect.
Tunicamycin
Figs. 1, 7, and 8 show that tunicamycin has a similar effect
on protein secretion to that of 1-deoxynojirimycin . The in-
hibition of secretion of al-antitrypsin and C3, as well as of
total [ 35S]methionine labeled secretory proteins, is the same
for both drugs . Inexplicably, tunicamycin has, reproducibly,
less of an inhibitory erect on secretion of al-antichymotryp-
sin than does 1-deoxynojirimycin . Nonglycosylated al-anti-
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￿
Subcellular distribution of labeled al -antichymotrypsin,
at-antitrypsin, albumin, and transferrin in control cells (left) and 1-
deoxynojirimycin-treated cells (right) after a 15-min pulse-label with
['SS]methionine and a 55-min chase . As is detailed in Materials and
Methods, microsomes were isolated from control and 1-deoxyno-
jirimycin-treated cells that had been pulse-labeled for 15 min and
chased for 55 min. These were centrifuged to equilibrium on a
sucrose gradient ; the density of each fraction is plotted at the top
of each figure . Of each fraction 100 juI was subjected to immuno-
precipitation by each of the five rabbit anti-human serum proteins
studied. For al -antitrypsin, it was necessary to preclear the fractions
first with normal rabbit serum and fixed S . aureus cells, followed by
the immune serum and additional S . aureus. This was necessary to
remove a minor nonspecific protein that migrated on the SDS gel
near the Endo H-sensitive form of a1-antitrypsin . The immunopre-
cipitates were analyzed by SDS gel electrophoresis and fluorogra-
phy. Theautoradiogram was scanned, and theareas under all peaks
determined . For a1-antitrypsin and al-antichymotrypsin, in the
control sample the radioactivity in the slow-migrating (Endo H-
resistant) "mature" form (x) and the total radioactivity in both
intracellular forms (Q) is plotted as a percentage of the total radio-
activity in this protein recovered from the gradient.-The small
amount of labeled protein at the top of the gradient (fractions 17-
19) represents material that has leaked from vesicles, and is not
depicted here nor included in calculations summarized in the text .
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trypsin (Fig . 7) and C3 (Fig. 8) as well as the other proteins
studied (not shown), are not degraded, but are secreted at a
characteristic slow rate.
DISCUSSION
This study focuses on the factors that determine the rates at
which individual secretory proteins are transported from the
rough endoplasmic reticulum to the Golgi complex. Of the
five serum proteins studied, albumin and al-antitrypsin are
normally transported the fastest, with half-times of-30 min
at 32°C . About 50 min are required for half of the al-
antichymotrypsin and C3 complement to be transported ;
transferrin, the slowest protein studied, takes 150 min . This
is the rate-limiting and distinctive step in maturation of
secretory proteins. Secretion of all proteins from the Golgi
requires about 20 min (at 32 °C) (20). Furthermore, swainson-
ine, an inhibitor ofthe Golgi enzyme a-mannosidase II (36),
has no effect on the rate of secretion of any of the proteins
studied (Fig . 1), even though the glycoproteins are released
with abnormal oligosaccharides (38-40) .
It is not known whether the rough endoplasmic reticulum
pool sizes of the various secretory proteins are different. As
movement ofmembrane (and presumably secretory) proteins
out of an intracellular pool is a random process (reference
21), one might imagine that differences in pool sizes of
individual protein species within the rough endoplasmic retic-
ulum would cause differences in secretion rates . However,
differences in the rough endoplasmic reticulum pool sizes are
expected to arise as a consequence of differences in rates of
transport of the different proteins to the Golgi, not as a cause
of different transport rates . Consider a compartment (the
rough endoplasmic reticulum) filled by two substances (pro-
teins) at the same rate (synthesis), but in which the two
substances exit at different rates (incorporation into transport
vesicles) . The substance that has the highest rate constant for
exit will have the lowest pool size in the compartment . This
conclusion is valid whether exit from the compartment is by
a nonsaturable first order process, or by a saturable process
involving binding of all of the substances to a common
receptor (H . Lodish, calculations not shown) .
HepG2 cells do have abundant cell surface receptors for
transferrin (46) . Addition of 50 kg/ml human transferrin to
HepG2 cells had no effect on the rate of transferrin secretion
(unpublished data), and in any case, there was no evidence
that endocytosed transferrin was ever transported to the rough
endoplasmic reticulum . Thus, it is unlikely that an intracel-
lular pool of transferrin, generated by endocytosis, affects the
transport oftransferrin from the rough endoplasmic reticulum
to the Golgi.
We have shown here that N-linked oligosaccharides play a
key role in the transport of some proteins from the rough
endoplasmic reticulum to the Golgi . The results are most
dramatic for al-antitrypsin . Nonglycosylated al-antitrypsin
is secreted only slowly and incompletely from HepG2 cells
(Figs . 1 and 7b) . Most of the labeled nonglycosylated al-
antitrypsin co-fractionates with rough endoplasmic reticulum
membrane vesicles, even after a long period of chase (data
not shown), a result indicating that at least one asn-linked
oligosaccharide is required for movement from the endo-
plasmic reticulum .
However, the addition ofan asn-linked oligosaccharide to
a 1-antitrypsin is not sufficient for normal maturation . Our
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Effect of tunicamycin on secretion of albumin (a) and a1-antitrypsin (b) . 16 plates were pulse-labeled with [' Is]-
methionine, eight in theabsence (lanes 1-8) and eight in the presence of tunicamycin . One set of cells was lysed after the pulse,
and others after chase periods of the indicated length . From the lysates albumin (a) or al-antitrypsin (b) were recovered by
immunoprecipitation and analyzed by gel electrophoresis and autoradiography .
results with 1-deoxynojirimycin, an inhibitor of glucosidases
I and 11, indicate that removal of at least oneglucose residue
is essential for rapid movement of al-antitrypsin from the
rough endoplasmic reticulum . This drug causes the intracel-
lular accumulation of high mannose oligosaccharides that
contain one or more glucose residues, and blocks theconver-
sion of high mannose to complex oligosaccharides (33, 34) .
1-deoxynojirimycin inhibits the secretion of al-antitrypsin
(Fig . 1 ; see also reference 34) and causes the protein to
accumulate in the rough endoplasmic reticulum (Fig. 6). As
judged by sensitivity to Endo H, intracellular al-antitrypsin
FIGURE 8
￿
Effect of tunicamycin on
secretion of C3 complement. The
protocol was identical to that of Fig.
7, except the medium was re-
covered after the different periods
of chase ; C3 was recovered by
quantitative immunoprecipitation
and analyzed by gel electrophoresis
and radioautography.
maintains high mannose oligosaccharides (Fig . 5) . Evidently,
the reduced rate of formation of complex sugars on al-
antitrypsin is due to its slowness in reaching the Golgi mem-
branes, wherein are localized the enzymes that convert high
mannose oligosaccharides to a complex form (4, 18) . Our
studies on the gel mobility and Endo H-sensitivity of intra-
cellulara1-antitrypsin, synthesized in the presence of 1-deox-
ynojirimycin, are consistent with an oligosaccharide compo-
sition of Glc,_3Man9GlcNAc2 (Figs . 3-5) ; a recent paper has
shown this directly (34) .
Inhibition of maturation of al-antitrypsin by 1-deoxynoji-
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1727rimycin is highly specific. This drug has no effect on secretion
of a 1-antitrypsin synthesized before the drug is added, though
it profoundly reduces secretion of the protein synthesized in
its presence . Furthermore, al-antitrypsin, synthesized in the
presence of 1-deoxynojirimycin, will be secreted after the
inhibitor is removed (Table II). Additionally, this drug has no
effect on secretion of albumin nor of transferrin (Fig. 1) .
1-deoxynojirimycin also reduces the rate of secretion of
al-antichymotrypsin . As with al-antitrypsin, it causes the
protein to accumulate in the rough endoplasmic reticulum
(Fig. 6) .
Precisely how asn-linked oligosaccharides influence mat-
uration of proteins from the rough endoplasmic reticulum to
the Golgi is not clear. Nonglycosylated proteins, synthesized
in the presence of tunicamycin, frequently are less soluble
than their normal counterparts or have an altered conforma-
tion that is reflected in enhanced sensitivity to proteases (see
Introduction). Such abnormally folded or denatured proteins
might precipitate on or in the endoplasmic reticulum mem-
brane . Presumably these explanationsdo not apply to proteins
synthesized in the presence of 1-deoxynojirimycin, since the
drug causes a normal processing intermediate (apparently
Glc l-3Man9GlcNAc2) to accumulate within the endoplasmic
reticulum.
It is possible that different vesicles are used to transport
different secretory products from the endoplasmic reticulum .
Implicit in this statement is the notion of a receptor protein
that binds to specific secretory proteins in the endoplasmic
reticulum membrane, and mediates their incorporation into
the appropriate transport vesicle . Alternatively, all secretory
proteins could be transported in the same vesicle . To explain
the different rates of transport of proteins to the Golgi, we
and others have postulatedthat one or more receptor proteins,
localized to a specific region of the lumenal surface of the
endoplasmic reticulum membrane, mediates the selective,
rapid transport of certain secretory and membrane glycopro-
teins (19-21) .
Albumin is normally transported to the Golgi very rapidly,
and its transport is unaffected by any inhibitor of glycosyla-
tion . Clearly, asn-linked oligosaccharides play no role in the
binding of albumin to any transport receptor.
The slow rate of transport of transferrin from the rough
endoplasmic reticulum is similarly unaffectedby tunicamycin
TABLE II
Inhibition of Secretion of a1-Antitrypsin by 1-Deoxynoiirimycin
Is Reversible
Five plates of HepG2 cells were placed in methionine-free medium in the
presence (samples 2-4) or absence (samples 1 and 5) of 1-deoxynojirimycin .
After a 20-min incubation, they were pulse-labeled for 10 min, then chased
for 240 min, In sample 2, 1-deoxynojirimycin was present throughout the
chase . In samples 3 and 4, the 1-deoxynojirimycin-containing chase medium
was removed at 30 min (sample 3) or 60 min (sample 4) and replaced with
fresh medium, without drugs. Incubation at 32°C was continued for a total
of 240 min. In sample 5, 1-deoxynojirimycin was added only after 20 min of
chase .
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or 1-deoxynojirimycin . We previously postulated that the slow
migration oftransferrin could be due to bulk phase (receptor-
independent)movement ofthe lumenal contents ofthe rough
endoplasmic reticulum, a process akin to pinocytosis ofextra-
cellular fluids into the cytoplasm.
Since a particular processing intermediate on the al-anti-
trypsin oligosaccharides is essential for its rapid transportfrom
the rough endoplasmic reticulum, we presume that this oli-
gosaccharide forms part of the receptor-binding sites on at
least this protein, and probably also al-antichymotrypsin.
The slow maturation of nonglycosylated a1-antitrypsin to the
Golgi, or of al-antitrypsin synthesized in the presence of 1-
deoxynojirimycin, might not involve binding at all to a recep-
tor, but rather bulk-phase fluid movement from the rough
endoplasmic reticulum to the Golgi . It is noteworthy that
both 1-deoxynojirimycin and tunicamycin cause a 1-antitryp-
sin and a1-antichymotrypsin to be secreted with the same
slow kinetics as is transferrin (Fig . 1) .
One might imagine that HepG2 cells contain different
glucosidase I or II enzymes that act on different secretory
proteins, that these enzymes have different sensitivities to 1-
deoxynojirimycin, and that removal of glucose residues is
essential for all glycoproteins to mature to the Golgi . Although
we cannot eliminate this possibility, we note that 1-deoxyno-
jirimycin concentrations from 5 to 25 mM had the same
differential erect on the secretion ofthe five proteins studied .
Thus it is unlikely thatwe did not achieve the full effect of 1-
deoxynojirimycin on protein secretion .
There are other explanations of our data that we cannot
eliminate . Removal ofthe glucose residue on the a1-antitryp-
sin oligosaccharides could induce a major change in the
protein conformation that, in turn, could be reflected in an
enhanced solubility in the endoplasmic reticulum lumen, (and
thus in a faster movement by bulk phase) or in an enhanced
binding to the putative receptor . Or, a specific receptor might
not be involved at all . Rather, removal of the three glucose
residues might modify some bulk property of the protein,
such as its aggregation or surface charge, that might affect its
incorporation into transport vesicles.
Bromoconduritol, a specific inhibitor ofglucosidase II, also
causes intracellular accumulation of high mannose oligosac-
charides . This drug inhibits generation of complex oligosac-
charides, and causes an inhibition of release of influenza
proteins into virions (43). However, it is not known where
the maturation ofthe influenza haemagluttinin or neuramin-
idase is blocked .
The secretory proteins that accumulate in cells treated with
1-deoxynojirimycin can be used to generate defined substrates
for use in experiments that attempt to identify such a transport
receptor. These studies are in progress.
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